Eastman Chemical (EMN) Form 3 EASTMAN CHEMICAL / Christopher Moore Killian ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Killian Christopher Moore

(Last) (First) (Middle)

200 S. WILCOX DRIVE

(Street)

KINGSPORT TN 37660

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/07/2021

3. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
SVP & CTO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2,249	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	02/26/2022(1)	02/25/2031	Common Stock	5,435	109.26	D
Employee Stock Option (right to buy)	02/28/2021(2)	02/27/2030	Common Stock	7,259	61.51	D
Employee Stock Option (right to buy)	10/15/2021(3)	10/15/2029	Common Stock	6,860	72.92	D
Employee Stock Option (right to buy)	02/28/2020(4)	02/27/2029	Common Stock	7,260	82.69	D
Employee Stock Option (right to buy)	02/26/2021	02/25/2028	Common Stock	6,478	104.21	D
Restricted Stock Units	12/01/2023(5)	12/01/2023(5)	Common Stock	5,062	(5)	D
Restricted Stock Units	10/15/2022(5)	10/15/2022(5)	Common Stock	1,715	(5)	D

Explanation of Responses:

1. One-third of option becomes exercisable on each of February 26, 2022, February 26, 2023, and February 26, 2024.

2. One-third of option became exercisable on February 28, 2021 and one-third of option becomes exercisable on each of February 28, 2022, and February 28, 2023.

3. One-half of option becomes exercisable on each of October 15, 2021 and October 15, 2022.

4. One-third of option became exercisable on each of February 28, 2020 and February 28, 2021 and one-third of option becomes exercisable on February 28, 2022.

5. Each Restricted Stock Unit represents a contingent right to receive one share of issuer common stock subject to continued employment.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Brian L. Henry, by Power of Attorney	06/16/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.